- Home
- MSM vs SLNO Comparison
MSM vs SLNO Comparison
Compare MSM & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSM
- SLNO
- Stock Information
- Founded
- MSM 1941
- SLNO 1999
- Country
- MSM United States
- SLNO United States
- Employees
- MSM N/A
- SLNO N/A
- Industry
- MSM Industrial Machinery/Components
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- MSM Industrials
- SLNO Health Care
- Exchange
- MSM Nasdaq
- SLNO Nasdaq
- Market Cap
- MSM 4.6B
- SLNO 3.8B
- IPO Year
- MSM 1995
- SLNO 2014
- Fundamental
- Price
- MSM $85.38
- SLNO $83.25
- Analyst Decision
- MSM Hold
- SLNO Strong Buy
- Analyst Count
- MSM 5
- SLNO 9
- Target Price
- MSM $85.40
- SLNO $103.33
- AVG Volume (30 Days)
- MSM 419.4K
- SLNO 915.0K
- Earning Date
- MSM 07-01-2025
- SLNO 08-06-2025
- Dividend Yield
- MSM 3.98%
- SLNO N/A
- EPS Growth
- MSM N/A
- SLNO N/A
- EPS
- MSM 3.80
- SLNO N/A
- Revenue
- MSM $3,751,835,000.00
- SLNO N/A
- Revenue This Year
- MSM N/A
- SLNO N/A
- Revenue Next Year
- MSM $3.66
- SLNO N/A
- P/E Ratio
- MSM $22.48
- SLNO N/A
- Revenue Growth
- MSM N/A
- SLNO N/A
- 52 Week Low
- MSM $68.10
- SLNO $36.93
- 52 Week High
- MSM $90.81
- SLNO $86.67
- Technical
- Relative Strength Index (RSI)
- MSM 63.95
- SLNO 62.72
- Support Level
- MSM $80.08
- SLNO $78.48
- Resistance Level
- MSM $82.45
- SLNO $86.67
- Average True Range (ATR)
- MSM 1.54
- SLNO 2.78
- MACD
- MSM 0.07
- SLNO 0.40
- Stochastic Oscillator
- MSM 98.85
- SLNO 67.95
About MSM MSC Industrial Direct Company Inc.
Founded in 1941, MSC Industrial Direct originally manufactured and sold cutting tools to metalworking shops in New York. Through a series of acquisitions and organic expansions, MSC has grown into an industrial distribution powerhouse with a focus on specialized metalworking products and services. The firm also distributes a wide breadth of maintenance, repair, and operations (MRO) supplies. MSC primarily operates within North America where it derives over 95% of its revenue.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.